La biopsia líquida en el diagnóstico y monitoreo de pacientes oncológicos: oportunidades y retos en Latinoamérica

IF 0.2 Q4 ONCOLOGY

Revista Colombiana de Cancerologia Pub Date : 2020-11-06 DOI:10.35509/01239015.44

S. Perdomo, Lorena Montealegre-Páez, Rafael Adrián Pacheco-Orozco, Héctor Martínez-Gregorio, Felipe Vaca-Paniagua, J. Ardila, Federico Cayol, J. Oliver, C. Frecha, Javier Cuello López, David Carreño

引用次数: 0

Abstract

ABSTRACT In recent years, the study of circulating nucleic acids has made great progress in the field of oncology, allowing for significant advances in clinical applications of liquid biopsy in diverse areas such as prognosis, staging, recurrence prediction, selection and monitoring of treatments, among others. This advance is largely due to the development of new and better technologies, some of which have even been validated for the diagnosis and clinical follow-up of certain types of cancer. However, the use of liquid biopsy as an additional tool in clinical oncology remains under study. Given the worldwide importance of this technological advance, a literature review was conducted to establish the current status of the use of liquid biopsy in oncology, as well as its current clinical applications, with a particular focus on Latin America.

查看原文本刊更多论文

液体活检在肿瘤患者诊断和监测中的应用:拉丁美洲的机遇和挑战

近年来，循环核酸的研究在肿瘤学领域取得了很大的进展，使得液体活检在预后、分期、复发预测、治疗方案的选择和监测等多个领域的临床应用取得了重大进展。这一进步主要是由于新的和更好的技术的发展，其中一些技术甚至已被证实用于某些类型癌症的诊断和临床随访。然而，液体活检作为临床肿瘤学的额外工具仍在研究中。鉴于这一技术进步在世界范围内的重要性，我们进行了一项文献综述，以确定液体活检在肿瘤学中的使用现状及其目前的临床应用，并特别关注拉丁美洲。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Revista Colombiana de Cancerologia ONCOLOGY-

自引率

50.00%

发文量

期刊介绍： The Revista Colombiana de Cancerología is an official publication of the Instituto Nacional de Colombia (INC). The Revista is published quarterly with the aim of broadening and disseminating knowledge in the field of oncology. The Revista publishes articles on: molecular carcinogenic mechanisms and treatment responses; cancer epidemiology; clinical features and treatment of neoplastic disease and public health campaigns to control cancer. Manuscripts which contain original material shall be accepted for possible publication. Neither the article nor any part of its contents (including statistical or graphic content) may have been published or submitted for publication in any media other than the Revista Colombiana de Cancerología. No acceptance shall be made of preliminary reports (abstracts or posters) presented at scientific meetings, neither of press releases on programmed meetings. All manuscript copies shall be placed at the disposition of the Journal Editorial Board. Under exceptional circumstances, secondary publications in Spanish or other languages may be submitted, provided they comply with certain conditions which justify said submission.